Acal (LON:ACL)‘s stock had its “buy” rating reissued by stock analysts at Peel Hunt in a research report issued to clients and investors on Tuesday, November 28th. They presently have a GBX 360 ($4.85) price objective on the stock. Peel Hunt’s price objective would suggest a potential downside of 0.55% from the company’s current price.
Several other analysts also recently commented on ACL. FinnCap reiterated a “buy” rating and issued a GBX 339 ($4.56) price target on shares of Acal in a research report on Tuesday, September 26th. Numis Securities reiterated a “buy” rating and issued a GBX 370 ($4.98) price target on shares of Acal in a research report on Monday, October 16th.
Acal (LON ACL) opened at GBX 362 ($4.87) on Tuesday. Acal has a twelve month low of GBX 210 ($2.83) and a twelve month high of GBX 365 ($4.91).
ACAL plc designs, manufactures and distributes electronic products and solutions. The Company operates through two segments: Custom Distribution and Design & Manufacturing. The Custom Distribution segment provides customized electronic, photonic and medical products to the industrial, medical and healthcare markets, both from a range of international suppliers and from the Company’s Design & Manufacturing division.
Receive News & Ratings for Acal plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acal plc and related companies with MarketBeat.com's FREE daily email newsletter.